1 402

Cited 10 times in

Potential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea

DC Field Value Language
dc.contributor.author성공제-
dc.date.accessioned2015-04-24T17:14:38Z-
dc.date.available2015-04-24T17:14:38Z-
dc.date.issued2009-
dc.identifier.issn1080-7683-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/105026-
dc.description.abstractPURPOSE: The aim of this study was to evaluate the potential benefit of intraocular pressure (IOP) reduction in normal tension glaucoma (NTG) Asian adult patients in South Korea. METHODS: This was a retrospective, multicenter analysis of 166 NTG Asian adult patients in South Korea. The patient population consisted of Korean patients with NTG with at least 5 years of records available for evaluation. Patients all had typical glaucomatous optic-disc and/or visual-field changes but had never had a recorded IOP >21 mmHg. RESULTS: Overall, 48 (29%) patients were progressed and 116 (71%) were stable over the follow-up period. Of patients with IOPs <or=14 mmHg (21/93), 23% progressed and >or=15 mmHg (27/73) 37% progressed (P = 0.041). The mean IOP for the stable group was 14.0 +/- 1.8 mmHg, whereas with the progressed group the average mean IOP was 14.4 +/- 1.6 mmHg (P = 0.20). The mean peak IOP was 17.4 +/- 2.2 mmHg in the stable group and 17.8 +/- 2.0 mmHg in the progressed group (P = 0.26). Multivariate linear regression analysis did not any identify independent risk factors for progression, including age, gender, or mean and peak IOP. CONCLUSIONS: This study provides initial evidence that Korean patients with normal-tension glaucoma, treated to lower IOPs, may have a decreased incidence of progression over 5 years than those patients with higher IOPs. More research is required to confirm this finding-
dc.description.statementOfResponsibilityopen-
dc.format.extent91~96-
dc.relation.isPartOfJOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAntihypertensive Agents/therapeutic use*-
dc.subject.MESHAsian Continental Ancestry Group-
dc.subject.MESHDisease Progression-
dc.subject.MESHFemale-
dc.subject.MESHGlaucoma, Open-Angle/drug therapy*-
dc.subject.MESHHumans-
dc.subject.MESHIntraocular Pressure/drug effects*-
dc.subject.MESHKorea/epidemiology-
dc.subject.MESHMale-
dc.subject.MESHOptic Disk/pathology-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHVisual Fields-
dc.titlePotential benefit of intraocular pressure reduction in normal-tension glaucoma in South Korea-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Ophthalmology (안과학)-
dc.contributor.googleauthorGong Je Seong-
dc.contributor.googleauthorSae Heun Rho-
dc.contributor.googleauthorChang Sik Kim-
dc.contributor.googleauthorJong Il Moon-
dc.contributor.googleauthorMichael Scott Kook-
dc.contributor.googleauthorYong Yeon Kim-
dc.contributor.googleauthorKyoung Tak Ma-
dc.contributor.googleauthorYoung Jae Hong-
dc.contributor.googleauthorLindsay A. Nelson-
dc.contributor.googleauthorBonnie Kruft-
dc.contributor.googleauthorJeanette A. Stewart-
dc.contributor.googleauthorWilliam C. Stewart-
dc.identifier.doi10.1089/jop.2008.0056-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01946-
dc.relation.journalcodeJ01654-
dc.identifier.eissn1557-7732-
dc.identifier.pmid19232005-
dc.identifier.urlhttp://online.liebertpub.com/doi/abs/10.1089/jop.2008.0056-
dc.contributor.alternativeNameSeong, Gong Je-
dc.contributor.affiliatedAuthorSeong, Gong Je-
dc.citation.volume25-
dc.citation.number1-
dc.citation.startPage91-
dc.citation.endPage96-
dc.identifier.bibliographicCitationJOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, Vol.25(1) : 91-96, 2009-
dc.identifier.rimsid56239-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.